Insider Selling: Ralliant (NYSE:RAL) SVP Sells $436,464.00 in Stock

Ralliant Corporation (NYSE:RAL) SVP Karen Bick sold 6,062 shares of Ralliant stock in a transaction on Monday, August 17th. The shares were sold at an average price of $72.00, for a total transaction of $436,464.00. Following the completion of the transaction, the senior vice president directly owned 31,668 shares of the company’s stock, valued at $2,280,096. The trade was a 16.07% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ralliant Trading Down 3.6%

RAL stock opened at $64.12 on Friday. The company’s 50-day simple moving average is $68.99 and its 200-day simple moving average is $55.86. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.75. Ralliant Corporation has a 52-week low of $37.27 and a 52-week high of $75.41. The firm has a market cap of $7.09 billion, a P/E ratio of -5.91, a PEG ratio of 2.47 and a beta of 1.60.

Ralliant (NYSE:RAL) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.05. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.The firm had revenue of $567.80 million during the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, equities analysts forecast that Ralliant Corporation will post 2.87 EPS for the current fiscal year.

Ralliant Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $0.05 per share. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. Ralliant’s dividend payout ratio (DPR) is -1.84%.

Institutional Investors Weigh In On Ralliant

A number of hedge funds have recently modified their holdings of RAL. Teacher Retirement System of Texas increased its stake in shares of Ralliant by 6.9% in the 4th quarter. Teacher Retirement System of Texas now owns 570,878 shares of the company’s stock worth $29,063,000 after acquiring an additional 36,800 shares during the last quarter. Irenic Capital Management LP boosted its position in shares of Ralliant by 424.1% during the 1st quarter. Irenic Capital Management LP now owns 1,740,218 shares of the company’s stock valued at $72,376,000 after acquiring an additional 1,408,176 shares during the last quarter. Rokos Capital Management LLP purchased a new stake in shares of Ralliant in the first quarter valued at about $42,022,000. California State Teachers Retirement System grew its holdings in shares of Ralliant by 23.1% in the first quarter. California State Teachers Retirement System now owns 130,822 shares of the company’s stock valued at $5,441,000 after purchasing an additional 24,591 shares during the period. Finally, Flossbach Von Storch SE acquired a new stake in Ralliant during the second quarter worth about $222,460,000.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. BMO Capital Markets began coverage on shares of Ralliant in a report on Monday, July 20th. They issued a “market perform” rating and a $78.00 price target for the company. Truist Financial reiterated a “buy” rating and issued a $82.00 target price (up from $68.00) on shares of Ralliant in a research report on Friday, July 31st. Wall Street Zen lowered shares of Ralliant from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, August 11th. TD Cowen upped their price target on shares of Ralliant from $70.00 to $80.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Finally, Morgan Stanley raised their price target on shares of Ralliant from $68.00 to $85.00 and gave the company an “overweight” rating in a research note on Tuesday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $75.70.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.